Literature DB >> 109184

Alterations of nutritional status: impact of chemotherapy and radiation therapy.

S S Donaldson, R A Lenon.   

Abstract

The nutritional status of a cancer patient may be affected by the tumor, the chemotherapy and/or radiation therapy directed against the tumor, and by complications associated with that therapy. Chemotherapy-radiotherapy is not confined exclusively to malignant cell populations; thus, normal tissues may also be affected by the therapy and may contribute to specific nutritional problems. Impaired nutrition due to anorexia, mucositis, nausea, vomiting, and diarrhea may be dependent upon the specific chemotherapeutic agent, dose, or schedule utilized. Similar side effects from radiation therapy depend upon the dose, fractionation, and volume irradiated. When combined modality treatment is given the nutritional consequences may be magnified. Prospective, randomized clinical trials are underway to investigate the efficacy of nutritional support during chemotherapy-radiotherapy on tolerance to treatment, complications from treatment, and response rates to treatment. Preliminary results demonstrate that the administration of total parenteral nutrition is successful in maintaining weight during radiation therapy and chemotherapy, but that weight loss occurs after discontinuation of nutritional support. Thus, long-term evaluation is mandatory to learn the impact of nutritional support on survival, disease-free survival, and complication rates, as well as on the possible prevention of morbidity associated with aggressive chemotherapy-radiation therapy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 109184     DOI: 10.1002/1097-0142(197905)43:5+<2036::aid-cncr2820430712>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  25 in total

1.  Changes in plasma amino acids during conditioning therapy prior to bone marrow transplantation: Their relevance to antioxidant status.

Authors:  A G Hunnisett; A Kars; J M Howard; S Davies
Journal:  Amino Acids       Date:  1993-02       Impact factor: 3.520

2.  Cisplatin-Impaired Adipogenic Differentiation of Adipose Mesenchymal Stem Cells1.

Authors:  Yu-Hsun Chang; Hwan-Wun Liu; Tang-Yuan Chu; Yao-Tseng Wen; Rong-Kung Tsai; Dah-Ching Ding
Journal:  Cell Transplant       Date:  2017-02-03       Impact factor: 4.064

3.  Effects of nutritional intervention in head and neck cancer patients undergoing radiotherapy: A prospective randomized clinical trial.

Authors:  Wen-Xing Kang; Wentao Li; Shi-Gao Huang; Yazhang Dang; Hongxiang Gao
Journal:  Mol Clin Oncol       Date:  2016-06-30

4.  Effects of protein depletion on NK cell cytotoxicity and bone marrow cellularity.

Authors:  R Ruffmann; E Schlick; T Tartaris; E Gruys; R D Welker; T Saito; M A Chirigos
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

Review 5.  Intestinal and liver toxicity of antineoplastic drugs.

Authors:  G B McDonald; N Tirumali
Journal:  West J Med       Date:  1984-02

Review 6.  [Pathogenesis and therapy of malnutrition in oncology].

Authors:  G Ollenschläger
Journal:  Z Ernahrungswiss       Date:  1982-06

Review 7.  The role of parenteral nutrition in acute leukemia.

Authors:  Nicole B Jacobson; Neha Parekh; Matt Kalaycio
Journal:  Curr Hematol Malig Rep       Date:  2006-09       Impact factor: 3.952

8.  Validation of a surgical technique for rat intestinal irradiation: potential side effects prevention by dietary grape phenolics.

Authors:  Lama Younes-Sakr; Pierre Senesse; Caroline Laurent; Jean-Max Rouanet; Nathalie Rugani; Jean-Paul Cristol; Sylvie Gaillet
Journal:  Dig Dis Sci       Date:  2012-05-22       Impact factor: 3.199

9.  Complications of percutaneous endoscopic gastrostomy tube insertion in cancer patients: a retrospective study.

Authors:  Hala Mansoor; Muhammad Adnan Masood; Muhammed Aasim Yusuf
Journal:  J Gastrointest Cancer       Date:  2014-12

Review 10.  A descriptive review of the factors contributing to nutritional compromise in patients with head and neck cancer.

Authors:  Martin R Chasen; Ravi Bhargava
Journal:  Support Care Cancer       Date:  2009-07-18       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.